Concord Medical Services Holdings Limited
CCM
$5.09
-$0.16-2.99%
NYSE
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -29.85% | -27.23% | -25.87% | -10.44% | 9.76% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -29.85% | -27.23% | -25.87% | -10.44% | 9.76% |
| Cost of Revenue | -25.92% | -25.17% | -25.47% | -16.25% | -5.70% |
| Gross Profit | -1.66% | 11.79% | 23.04% | 40.88% | 52.61% |
| SG&A Expenses | 15.60% | 3.16% | -10.25% | -5.81% | -1.19% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -9.91% | -14.70% | -20.07% | -12.45% | -4.01% |
| Operating Income | -13.30% | -0.39% | 12.87% | 14.58% | 16.24% |
| Income Before Tax | -18.93% | 3.82% | 20.77% | 28.91% | 36.60% |
| Income Tax Expenses | 31.29% | 75.55% | 88.79% | 78.31% | 65.53% |
| Earnings from Continuing Operations | -21.31% | -2.50% | 12.74% | 23.78% | 33.98% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 44.86% | 24.13% | 3.66% | -9.32% | -20.83% |
| Net Income | -2.68% | 11.33% | 21.60% | 31.89% | 41.64% |
| EBIT | -13.30% | -0.39% | 12.87% | 14.58% | 16.24% |
| EBITDA | -19.45% | -2.46% | 16.69% | 20.32% | 23.61% |
| EPS Basic | -2.68% | 11.33% | 21.60% | 31.89% | 41.64% |
| Normalized Basic EPS | 75.72% | 25.40% | -46.41% | -46.41% | -46.41% |
| EPS Diluted | -2.68% | 11.32% | 21.59% | 31.87% | 41.61% |
| Normalized Diluted EPS | 75.72% | 25.40% | -46.41% | -46.41% | -46.41% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |